Viewing StudyNCT00085280



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00085280
Status: COMPLETED
Last Update Posted: 2014-03-31
First Post: 2004-06-10

Brief Title: Erlotinib in Treating Patients With Stage IIIB Stage IV or Recurrent Non-Small Cell Lung Cancer
Sponsor:
Organization: National Cancer Institute NCI